Priser
Platform
Blog
Om os
Download
NexgenRx
NexgenRx
TSX Venture Exchange
0

Om

NexgenRx Inc. operates as a progressive healthcare technology company specializing in the delivery of pharmacy and health benefits administration services. Its primary function is to provide efficient solutions in managing group benefit plans, directly impacting the administration side of healthcare service delivery. The technology infrastructure developed by NexgenRx is designed to streamline the claims adjudication process, ensuring accuracy and speed in benefit management while reducing unnecessary costs. NexgenRx's focus extends across diverse industries that require employee benefit solutions, impacting sectors such as corporate businesses, insurance firms, and public sector organizations. The company plays a pivotal role in the financial market by offering innovative technology-driven solutions that enhance the overall efficiency of health benefits administration, helping businesses meet both regulatory compliance and employee satisfaction goals. Established as a key player in the benefits management industry, NexgenRx continues to influence how group benefits are administered in the digital age.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I NEXGENRX MED ENDAVU: Køb NexgenRx ($NXG) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i NexgenRx, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

TickerNXG
Land
Canada
Hjemmesidenexgenrx.com
SektorSundhed
IndustriSundhedsinformationstjenester

Udbytter

0,01CAD
'22
0,01CAD
'23
0,01CAD
'24
0,02CAD
'25
0,01CAD
'26
Ex-udbytte-dato24. apr. 2026
Udbytteafkast2,7%